Teladoc Health Q2 adjusted loss beats estimates on Integrated Care strength

Earnings
โดย Zacks Investment Research·Read original
Summary · why it matters

Teladoc Health reported a second-quarter 2026 adjusted loss of 21 cents per share, beating the Zacks Consensus Estimate of a loss of 24 cents but widening from a loss of 19 cents a year earlier. Operating revenues declined 4% year over year to $606.9 million, missing the consensus estimate by 1.3%, as strength in the Integrated Care segment and higher international revenues were offset by weakness in the BetterHelp segment. Integrated Care revenues rose 1% to $394.3 million with adjusted EBITDA up 14% to $65.2 million, while BetterHelp revenues fell 12% to $212.6 million and adjusted EBITDA plunged 96% to $0.47 million. Total visits dipped 2% to 4.1 million, and U.S. Integrated Care members declined 2% to 100.3 million. For the third quarter, Teladoc expects total revenues between $569 million and $609 million and adjusted EBITDA between $62 million and $74 million, while full-year revenue guidance was lowered to a range of $2.362 billion to $2.447 billion.

Impact on stocks 4

Health Care · 3 stocks
Teladoc Inc
TDOC
▼ NegativeCapitalrelevance

Q2 revenue miss, BetterHelp weakness, and lowered full-year guidance

Aging Population · 1 stocks